Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07036705 · ClinicalTrials.gov registry record · NA

Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2

A NA study of Insomnia Disorder, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07036705 is a NA study of Insomnia Disorder that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants, below the 470-participant average among 8 other Insomnia Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07036705, a NA study of Insomnia Disorder, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This two-arm randomized trial will provide digital cognitive behavioral therapy for insomnia (CBT-I) to all participants and passive body heating (PBH) sessions using a sauna blanket to half of participants over a 9-week treatment period. Participants are adults aged 18 years or older with insomnia disorder.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Insomnia (CBT-I)
  • DEVICE Passive Body Heating (PBH)

Study Locations (1)

California

  • Osher Center for Integrative Health - San Francisco

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-29
Est. Completion 2027-07
Phase NA

What the Registry Record Tells You About NCT07036705

The ClinicalTrials.gov registry entry for NCT07036705 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 470-participant average among 8 other Insomnia Disorder trials with a reported enrollment target (91% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first listed.

NCT07036705 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07036705 about?

NCT07036705 is a clinical study titled "Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2". This two-arm randomized trial will provide digital cognitive behavioral therapy for insomnia (CBT-I) to all participants and passive body heating (PBH) sessions using a sauna blanket to half of participants over a 9-week treatment period. Participants are adults aged 18 years or older with insomnia ...

What is the current status of trial NCT07036705?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-29. Estimated completion is 2027-07.

What conditions does trial NCT07036705 study?

This clinical trial studies the following conditions: Insomnia Disorder.

What interventions are being tested in trial NCT07036705?

The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (CBT-I) (BEHAVIORAL), Passive Body Heating (PBH) (DEVICE).

Who is sponsoring clinical trial NCT07036705?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07036705 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.